NC-11813

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNC-11813
Drug Alias Nametau exon 10 splicing inhibitor (Eli Lilly/Nymirum)NC-11813
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau modulators
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBase4 Biotechnology IncEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A